Admission Troponin T Level Predicts Clinical Outcomes, TIMI Flow, and Myocardial Tissue Perfusion After Primary Percutaneous Intervention for Acute ST-Segment Elevation Myocardial Infarction
Authors:
- 7 August 2001
- journal article
- other
- Published by Wolters Kluwer Health in Circulation
- Vol. 104 (6) , 630-635
Abstract
Background — In ST-segment elevation myocardial infarction, a troponin T ≥0.1 μg/L on admission indicates poorer prognosis despite early reperfusion. To evaluate the underlying reason, we studied the value of cardiac troponin T (cTnT) for prediction of outcomes, epicardial blood flow, and myocardial reperfusion after primary percutaneous intervention. Methods and Results — Patients (n=140) admitted within 12 hours after onset of symptoms were stratified by admission cTnT. Epicardial and myocardial reperfusion were graded by the TIMI score and by measurement of relative increases of myoglobin, cTnT, and creatine kinase (CK)-MB 60 minutes after recanalization, respectively. cTnT was positive in 64 patients (45.7%) and was associated with longer median time intervals to admission (5.5 versus 3.5 hours, P P =0.06) and 9 months (14% versus 3.9%, P =0.005). cTnT independently predicted a 3.2-fold risk for incomplete epicardial reperfusion ( P =0.03). In addition, cTnT ≥0.1 μg/L was associated with more severely impaired myocardial perfusion despite normal epicardial flow, as indicated by lower 60-minute ratios of myoglobin (2.6 versus 7.6, P =0.007), cTnT (6.6 versus 29.2, P P =0.002) and a tendency for less resolution of ST-segment elevations (54% versus 60%, P =0.08). Conclusions — cTnT predicts poorer clinical outcomes, lower rates of postprocedural TIMI 3 flow, and more severely compromised myocardial perfusion despite normal epicardial flow. Thus, a cTnT-positive patient may require more aggressive adjunctive therapy when treated by percutaneous coronary intervention. The impact of preexisting or evolving microvascular dysfunction and the effect of therapies that target myocardial perfusion require further prospective evaluation.Keywords
This publication has 19 references indexed in Scilit:
- Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysisJACC, 2000
- Risk stratification with a point-of-care cardiac troponin T test in acute myocardial infarctionThe American Journal of Cardiology, 1999
- Myoglobin, creatine-kinase-MB and cardiac troponin-I 60-minute ratios predict infarct-related artery patency after thrombolysis for acute myocardial infarctionJACC, 1999
- Reperfusion revisited: Beyond TIMI3 flowClinical Cardiology, 1999
- Cardiac Troponin T Levels for Risk Stratification in Acute Myocardial IschemiaNew England Journal of Medicine, 1996
- Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patientsThe Lancet, 1994
- Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarctionThe American Journal of Cardiology, 1991
- Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute myocardial infarction: use of the ST segment as a non-invasive marker.Heart, 1988
- Noninvasive detection of coronary artery patency using continuous ST-segment monitoringThe American Journal of Cardiology, 1986
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985